BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 18347589)

  • 1. OTU takes the chains OUT.
    Balakirev MY; Wilkinson KD
    Nat Chem Biol; 2008 Apr; 4(4):227-8. PubMed ID: 18347589
    [No Abstract]   [Full Text] [Related]  

  • 2. Itching to end NF-kappaB.
    Heissmeyer V; Rao A
    Nat Immunol; 2008 Mar; 9(3):227-9. PubMed ID: 18285770
    [No Abstract]   [Full Text] [Related]  

  • 3. RNF11, a new piece in the A20 puzzle.
    Jacque E; Ley SC
    EMBO J; 2009 Mar; 28(5):455-6. PubMed ID: 19262463
    [No Abstract]   [Full Text] [Related]  

  • 4. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling.
    Wertz IE; O'Rourke KM; Zhou H; Eby M; Aravind L; Seshagiri S; Wu P; Wiesmann C; Baker R; Boone DL; Ma A; Koonin EV; Dixit VM
    Nature; 2004 Aug; 430(7000):694-9. PubMed ID: 15258597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the A20 OTU domain and mechanistic insights into deubiquitination.
    Komander D; Barford D
    Biochem J; 2008 Jan; 409(1):77-85. PubMed ID: 17961127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.
    Lin SC; Chung JY; Lamothe B; Rajashankar K; Lu M; Lo YC; Lam AY; Darnay BG; Wu H
    J Mol Biol; 2008 Feb; 376(2):526-40. PubMed ID: 18164316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structural biology of ubiquitin signaling].
    Nishimasu H; Ishitani R; Nureki O
    Seikagaku; 2013 Jun; 85(6):423-9. PubMed ID: 23875469
    [No Abstract]   [Full Text] [Related]  

  • 8. Deubiquitinases in the regulation of NF-κB signaling.
    Harhaj EW; Dixit VM
    Cell Res; 2011 Jan; 21(1):22-39. PubMed ID: 21119682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions.
    Heyninck K; Beyaert R
    Trends Biochem Sci; 2005 Jan; 30(1):1-4. PubMed ID: 15653317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biology of A20-like molecules.
    Enesa K; Evans P
    Adv Exp Med Biol; 2014; 809():33-48. PubMed ID: 25302364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ligase Itch negatively regulates inflammatory signaling pathways by controlling the function of the ubiquitin-editing enzyme A20.
    Shembade N; Harhaj NS; Parvatiyar K; Copeland NG; Jenkins NA; Matesic LE; Harhaj EW
    Nat Immunol; 2008 Mar; 9(3):254-62. PubMed ID: 18246070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of A20 in B-cell lymphomas].
    Kato M; Ogawa S
    Rinsho Ketsueki; 2011 Apr; 52(4):190-7. PubMed ID: 21566404
    [No Abstract]   [Full Text] [Related]  

  • 13. A20 is a negative regulator of BCL10- and CARMA3-mediated activation of NF-kappaB.
    Stilo R; Varricchio E; Liguoro D; Leonardi A; Vito P
    J Cell Sci; 2008 Apr; 121(Pt 8):1165-71. PubMed ID: 18349075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic expression of A20 prevents cardiac cell death and myocardial dysfunction after myocardial infarction.
    Shaw J; Eydelnant IA; Kirshenbaum LA
    Circulation; 2007 Apr; 115(14):1827-9. PubMed ID: 17420361
    [No Abstract]   [Full Text] [Related]  

  • 15. Selective binding of linear ubiquitin chains to NEMO in NF-kappaB activation.
    Ikeda F; Rahighi S; Wakatsuki S; Dikic I
    Adv Exp Med Biol; 2011; 691():107-14. PubMed ID: 21153314
    [No Abstract]   [Full Text] [Related]  

  • 16. A20: from ubiquitin editing to tumour suppression.
    Hymowitz SG; Wertz IE
    Nat Rev Cancer; 2010 May; 10(5):332-41. PubMed ID: 20383180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A20--a bipartite ubiquitin editing enzyme with immunoregulatory potential.
    Wertz I; Dixit V
    Adv Exp Med Biol; 2014; 809():1-12. PubMed ID: 25302362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of A20 and other OTU deubiquitinases by reversible oxidation.
    Kulathu Y; Garcia FJ; Mevissen TE; Busch M; Arnaudo N; Carroll KS; Barford D; Komander D
    Nat Commun; 2013; 4():1569. PubMed ID: 23463012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Foreword. The multiple therapeutic targets of A20.
    LoGerfo FW
    Adv Exp Med Biol; 2014; 809():vii-viii. PubMed ID: 25302360
    [No Abstract]   [Full Text] [Related]  

  • 20. Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling.
    Bibeau-Poirier A; Servant MJ
    Cytokine; 2008 Sep; 43(3):359-67. PubMed ID: 18707898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.